Radioimmunotherapy

Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY).

Also Known As:

Immunoradiotherapy; Immunoradiotherapies; Radioimmunotherapies

Therapeutics: 15318
- Radiotherapy: 68559
  - Radioimmunotherapy: 1663
- Combined Modality Therapy: 2381
  - Radioimmunotherapy: 1663
- Biological Therapy: 2317
  - Immunomodulation: 2883
    - Immunotherapy: 27262
      - Radioimmunotherapy: 1663

O A Gansow Selected Research

O A Gansow Research Topics

Disease

Therapy/Procedure